Ischemia Reperfusion Injury Market Report

China Ischemia Reperfusion Injury Industry Market Research Report 2023-2029

  • POSTDATE：Oct 15, 2023
  • PAGES：163
  • REPORT CODE：GMM1857379
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Reperfusion injury or reperfusion insult, sometimes called ischemia-reperfusion injury (IRI) or reoxygenation injury, is the tissue damage caused when blood supply returns to tissue (re- + perfusion) after a period of ischemia or lack of oxygen (anoxia or hypoxia). The absence of oxygen and nutrients from blood during the ischemic period creates a condition in which the restoration of circulation results in inflammation and oxidative damage through the induction of oxidative stress rather than (or along with) restoration of normal function.

    This report elaborates on the current development of the Ischemia Reperfusion Injury industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Omeros Corp

    • Bolder Biotechnology

    • SBI Pharmaceuticals

    • NovelMed Therapeutics

    • Hope Pharmaceuticals

    • Corline Biomedical

    • Ischemix Inc

    • TheraSource

    • Pharming

    • Prothix

    • Opsona Therapeutics

    • Angion Biomedica

    • Catalyst Biosciences

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By Application:

    • Other Injury

    • Kidney Injury

    • Heart Injury

    • Intestine Injury

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Ischemia Reperfusion Injury Market Overview 2018-2029

    • 1.1 China Ischemia Reperfusion Injury Industry Development Overview

    • 1.2 China Ischemia Reperfusion Injury Industry Development History

    • 1.3 China Ischemia Reperfusion Injury Industry Market Size (2018-2029)

    • 1.4 China Ischemia Reperfusion Injury Market Analysis by Type from Production Side

      • 1.4.1 China Ischemia Reperfusion Injury Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

      • 1.4.2 China Ischemia Reperfusion Injury Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

      • 1.4.3 China Ischemia Reperfusion Injury Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • 1.5 China Ischemia Reperfusion Injury Market Analysis by Application from Consumption End

      • 1.5.1 China Ischemia Reperfusion Injury Sales Volume, Sales Value and Growth Rate of Other Injury (2018-2029)

      • 1.5.2 China Ischemia Reperfusion Injury Sales Volume, Sales Value and Growth Rate of Kidney Injury (2018-2029)

      • 1.5.3 China Ischemia Reperfusion Injury Sales Volume, Sales Value and Growth Rate of Heart Injury (2018-2029)

      • 1.5.4 China Ischemia Reperfusion Injury Sales Volume, Sales Value and Growth Rate of Intestine Injury (2018-2029)

    • 1.6 China Ischemia Reperfusion Injury Market Analysis by Region

      • 1.6.1 North China Ischemia Reperfusion Injury Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Ischemia Reperfusion Injury Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Ischemia Reperfusion Injury Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Ischemia Reperfusion Injury Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Ischemia Reperfusion Injury Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Ischemia Reperfusion Injury Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Ischemia Reperfusion Injury Market Size and Growth Rate from 2018-2029

    Chapter 2 China Ischemia Reperfusion Injury Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Ischemia Reperfusion Injury Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Ischemia Reperfusion Injury Market Status and Competition Analysis in 2023

      • 2.2.3 China Ischemia Reperfusion Injury Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Ischemia Reperfusion Injury Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Ischemia Reperfusion Injury Industry Development

    Chapter 3 Ischemia Reperfusion InjuryIndustry Chain Analysis

    • 3.1 Ischemia Reperfusion Injury Industry Chain

    • 3.2 Ischemia Reperfusion Injury Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Ischemia Reperfusion Injury Market

    • 3.3 Ischemia Reperfusion Injury Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Ischemia Reperfusion Injury Market

    Chapter 4 China Ischemia Reperfusion Injury Market, by Type

    • 4.1 China Ischemia Reperfusion Injury Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Ischemia Reperfusion Injury Total Production Volume and Growth Rate from Production Side

    • 4.5 China Ischemia Reperfusion Injury Production Volume and Growth Rate, by Type

      • 4.5.1 China Ischemia Reperfusion Injury Production Volume and Growth Rate of Type 1

      • 4.5.2 China Ischemia Reperfusion Injury Production Volume and Growth Rate of Type 2

      • 4.5.3 China Ischemia Reperfusion Injury Production Volume and Growth Rate of Type 3

    Chapter 5 China Ischemia Reperfusion Injury Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Ischemia Reperfusion Injury Total Market Size and Growth Rate from Consumption End

    • 5.5 China Ischemia Reperfusion Injury Market Size and Growth Rate, by Application

      • 5.5.1 China Ischemia Reperfusion Injury Market Size and Growth Rate of Other Injury

      • 5.5.2 China Ischemia Reperfusion Injury Market Size and Growth Rate of Kidney Injury

      • 5.5.3 China Ischemia Reperfusion Injury Market Size and Growth Rate of Heart Injury

      • 5.5.4 China Ischemia Reperfusion Injury Market Size and Growth Rate of Intestine Injury

    Chapter 6 China Ischemia Reperfusion Injury Market, by Region

    • 6.1 China Ischemia Reperfusion Injury Production Volume and Production Value, by Region

    • 6.2 China Ischemia Reperfusion Injury Sales Volume and Sales Value, by Region

    Chapter 7 North China Ischemia Reperfusion Injury Market Analysis

    • 7.1 North China Ischemia Reperfusion Injury Market, by Type

    • 7.2 North China Ischemia Reperfusion Injury Market, by Application

    Chapter 8 Central China Ischemia Reperfusion Injury Market Analysis

    • 8.1 Central China Ischemia Reperfusion Injury Market, by Type

    • 8.2 Central China Ischemia Reperfusion Injury Market, by Application

    Chapter 9 South China Ischemia Reperfusion Injury Market Analysis

    • 9.1 South China Ischemia Reperfusion Injury Market, by Type

    • 9.2 South China Ischemia Reperfusion Injury Market, by Application

    Chapter 10 East China Ischemia Reperfusion Injury Market Analysis

    • 10.1 East China Ischemia Reperfusion Injury Market, by Type

    • 10.2 East China Ischemia Reperfusion Injury Market, by Application

    Chapter 11 Northeast China Ischemia Reperfusion Injury Market Analysis

    • 11.1 Northeast China Ischemia Reperfusion Injury Market, by Type

    • 11.2 Northeast China Ischemia Reperfusion Injury Market, by Application

    Chapter 12 Southwest China Ischemia Reperfusion Injury Market Analysis

    • 12.1 Southwest China Ischemia Reperfusion Injury Market, by Type

    • 12.2 Southwest China Ischemia Reperfusion Injury Market, by Application

    Chapter 13 Northwest China Ischemia Reperfusion Injury Market Analysis

    • 13.1 Northwest China Ischemia Reperfusion Injury Market, by Type

    • 13.2 Northwest China Ischemia Reperfusion Injury Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Omeros Corp

        • 14.1.1 Omeros Corp Company Profile

        • 14.1.2 Omeros Corp Ischemia Reperfusion Injury Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bolder Biotechnology

        • 14.2.1 Bolder Biotechnology Company Profile

        • 14.2.2 Bolder Biotechnology Ischemia Reperfusion Injury Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 SBI Pharmaceuticals

        • 14.3.1 SBI Pharmaceuticals Company Profile

        • 14.3.2 SBI Pharmaceuticals Ischemia Reperfusion Injury Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 NovelMed Therapeutics

        • 14.4.1 NovelMed Therapeutics Company Profile

        • 14.4.2 NovelMed Therapeutics Ischemia Reperfusion Injury Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Hope Pharmaceuticals

        • 14.5.1 Hope Pharmaceuticals Company Profile

        • 14.5.2 Hope Pharmaceuticals Ischemia Reperfusion Injury Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Corline Biomedical

        • 14.6.1 Corline Biomedical Company Profile

        • 14.6.2 Corline Biomedical Ischemia Reperfusion Injury Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Ischemix Inc

        • 14.7.1 Ischemix Inc Company Profile

        • 14.7.2 Ischemix Inc Ischemia Reperfusion Injury Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 TheraSource

        • 14.8.1 TheraSource Company Profile

        • 14.8.2 TheraSource Ischemia Reperfusion Injury Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Pharming

        • 14.9.1 Pharming Company Profile

        • 14.9.2 Pharming Ischemia Reperfusion Injury Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Prothix

        • 14.10.1 Prothix Company Profile

        • 14.10.2 Prothix Ischemia Reperfusion Injury Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Opsona Therapeutics

        • 14.11.1 Opsona Therapeutics Company Profile

        • 14.11.2 Opsona Therapeutics Ischemia Reperfusion Injury Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Angion Biomedica

        • 14.12.1 Angion Biomedica Company Profile

        • 14.12.2 Angion Biomedica Ischemia Reperfusion Injury Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Catalyst Biosciences

        • 14.13.1 Catalyst Biosciences Company Profile

        • 14.13.2 Catalyst Biosciences Ischemia Reperfusion Injury Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Ischemia Reperfusion Injury Industry Research Conclusions

    • 15.2 Ischemia Reperfusion Injury Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Ischemia Reperfusion Injury Industry Market Size (2018-2029)

    • Figure China Ischemia Reperfusion Injury Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

    • Figure China Ischemia Reperfusion Injury Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

    • Figure China Ischemia Reperfusion Injury Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • Figure China Ischemia Reperfusion Injury Sales Volume, Sales Value and Growth Rate of Other Injury (2018-2029)

    • Figure China Ischemia Reperfusion Injury Sales Volume, Sales Value and Growth Rate of Kidney Injury (2018-2029)

    • Figure China Ischemia Reperfusion Injury Sales Volume, Sales Value and Growth Rate of Heart Injury (2018-2029)

    • Figure China Ischemia Reperfusion Injury Sales Volume, Sales Value and Growth Rate of Intestine Injury (2018-2029)

    • Figure North China Ischemia Reperfusion Injury Market Size and Growth Rate from 2018-2029

    • Figure Central China Ischemia Reperfusion Injury Market Size and Growth Rate from 2018-2029

    • Figure South China Ischemia Reperfusion Injury Market Size and Growth Rate from 2018-2029

    • Figure East China Ischemia Reperfusion Injury Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Ischemia Reperfusion Injury Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Ischemia Reperfusion Injury Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Ischemia Reperfusion Injury Market Size and Growth Rate from 2018-2029

    • Figure Ischemia Reperfusion Injury Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Ischemia Reperfusion Injury Market Share by Type in 2018

    • Figure China Ischemia Reperfusion Injury Market Share by Type in 2023

    • Figure China Ischemia Reperfusion Injury Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Ischemia Reperfusion Injury Production Volume and Growth Rate of Type 1 (2018-2023)

    • Figure China Ischemia Reperfusion Injury Production Volume and Growth Rate of Type 2 (2018-2023)

    • Figure China Ischemia Reperfusion Injury Production Volume and Growth Rate of Type 3 (2018-2023)

    • Figure China Ischemia Reperfusion Injury Market Share by Application in 2018

    • Figure China Ischemia Reperfusion Injury Market Share by Application in 2023

    • Figure China Ischemia Reperfusion Injury Total Market Size and Growth Rate from Consumption End

    • Figure China Ischemia Reperfusion Injury Market Size and Growth Rate of Other Injury (2018-2023)

    • Figure China Ischemia Reperfusion Injury Market Size and Growth Rate of Kidney Injury (2018-2023)

    • Figure China Ischemia Reperfusion Injury Market Size and Growth Rate of Heart Injury (2018-2023)

    • Figure China Ischemia Reperfusion Injury Market Size and Growth Rate of Intestine Injury (2018-2023)

    • Table China Ischemia Reperfusion Injury Production Volume by Region (2018-2023)

    • Table China Ischemia Reperfusion Injury Production Volume Share by Region (2018-2023)

    • Figure China Ischemia Reperfusion Injury Production Volume Share by Region (2018-2023)

    • Table China Ischemia Reperfusion Injury Production Value by Region (2018-2023)

    • Table China Ischemia Reperfusion Injury Production Value Share by Region (2018-2023)

    • Figure China Ischemia Reperfusion Injury Production Value Share by Region (2018-2023)

    • Table China Ischemia Reperfusion Injury Sales Volume by Region (2018-2023)

    • Table China Ischemia Reperfusion Injury Sales Volume Share by Region (2018-2023)

    • Figure China Ischemia Reperfusion Injury Sales Volume Share by Region (2018-2023)

    • Table China Ischemia Reperfusion Injury Sales Value by Region (2018-2023)

    • Table China Ischemia Reperfusion Injury Sales Value Share by Region (2018-2023)

    • Figure China Ischemia Reperfusion Injury Sales Value Share by Region (2018-2023)

    • Table North China Ischemia Reperfusion Injury Production Volume by Type (2018-2023)

    • Table North China Ischemia Reperfusion Injury Production Volume Share by Type (2018-2023)

    • Figure North China Ischemia Reperfusion Injury Production Volume Share by Type (2018-2023)

    • Table North China Ischemia Reperfusion Injury Sales Volume by Application (2018-2023)

    • Table North China Ischemia Reperfusion Injury Sales Volume Share by Application (2018-2023)

    • Figure North China Ischemia Reperfusion Injury Sales Volume Share by Application (2018-2023)

    • Table Central China Ischemia Reperfusion Injury Production Volume by Type (2018-2023)

    • Table Central China Ischemia Reperfusion Injury Production Volume Share by Type (2018-2023)

    • Figure Central China Ischemia Reperfusion Injury Production Volume Share by Type (2018-2023)

    • Table Central China Ischemia Reperfusion Injury Sales Volume by Application (2018-2023)

    • Table Central China Ischemia Reperfusion Injury Sales Volume Share by Application (2018-2023)

    • Figure Central China Ischemia Reperfusion Injury Sales Volume Share by Application (2018-2023)

    • Table South China Ischemia Reperfusion Injury Production Volume by Type (2018-2023)

    • Table South China Ischemia Reperfusion Injury Production Volume Share by Type (2018-2023)

    • Figure South China Ischemia Reperfusion Injury Production Volume Share by Type (2018-2023)

    • Table South China Ischemia Reperfusion Injury Sales Volume by Application (2018-2023)

    • Table South China Ischemia Reperfusion Injury Sales Volume Share by Application (2018-2023)

    • Figure South China Ischemia Reperfusion Injury Sales Volume Share by Application (2018-2023)

    • Table East China Ischemia Reperfusion Injury Production Volume by Type (2018-2023)

    • Table East China Ischemia Reperfusion Injury Production Volume Share by Type (2018-2023)

    • Figure East China Ischemia Reperfusion Injury Production Volume Share by Type (2018-2023)

    • Table East China Ischemia Reperfusion Injury Sales Volume by Application (2018-2023)

    • Table East China Ischemia Reperfusion Injury Sales Volume Share by Application (2018-2023)

    • Figure East China Ischemia Reperfusion Injury Sales Volume Share by Application (2018-2023)

    • Table Northeast China Ischemia Reperfusion Injury Production Volume by Type (2018-2023)

    • Table Northeast China Ischemia Reperfusion Injury Production Volume Share by Type (2018-2023)

    • Figure Northeast China Ischemia Reperfusion Injury Production Volume Share by Type (2018-2023)

    • Table Northeast China Ischemia Reperfusion Injury Sales Volume by Application (2018-2023)

    • Table Northeast China Ischemia Reperfusion Injury Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Ischemia Reperfusion Injury Sales Volume Share by Application (2018-2023)

    • Table Southwest China Ischemia Reperfusion Injury Production Volume by Type (2018-2023)

    • Table Southwest China Ischemia Reperfusion Injury Production Volume Share by Type (2018-2023)

    • Figure Southwest China Ischemia Reperfusion Injury Production Volume Share by Type (2018-2023)

    • Table Southwest China Ischemia Reperfusion Injury Sales Volume by Application (2018-2023)

    • Table Southwest China Ischemia Reperfusion Injury Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Ischemia Reperfusion Injury Sales Volume Share by Application (2018-2023)

    • Table Northwest China Ischemia Reperfusion Injury Production Volume by Type (2018-2023)

    • Table Northwest China Ischemia Reperfusion Injury Production Volume Share by Type (2018-2023)

    • Figure Northwest China Ischemia Reperfusion Injury Production Volume Share by Type (2018-2023)

    • Table Northwest China Ischemia Reperfusion Injury Sales Volume by Application (2018-2023)

    • Table Northwest China Ischemia Reperfusion Injury Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Ischemia Reperfusion Injury Sales Volume Share by Application (2018-2023)

    • Table Omeros Corp Company Profile

    • Table Omeros Corp Ischemia Reperfusion Injury Revenue, Price and Gross (2018-2023)

    • Table Bolder Biotechnology Company Profile

    • Table Bolder Biotechnology Ischemia Reperfusion Injury Revenue, Price and Gross (2018-2023)

    • Table SBI Pharmaceuticals Company Profile

    • Table SBI Pharmaceuticals Ischemia Reperfusion Injury Revenue, Price and Gross (2018-2023)

    • Table NovelMed Therapeutics Company Profile

    • Table NovelMed Therapeutics Ischemia Reperfusion Injury Revenue, Price and Gross (2018-2023)

    • Table Hope Pharmaceuticals Company Profile

    • Table Hope Pharmaceuticals Ischemia Reperfusion Injury Revenue, Price and Gross (2018-2023)

    • Table Corline Biomedical Company Profile

    • Table Corline Biomedical Ischemia Reperfusion Injury Revenue, Price and Gross (2018-2023)

    • Table Ischemix Inc Company Profile

    • Table Ischemix Inc Ischemia Reperfusion Injury Revenue, Price and Gross (2018-2023)

    • Table TheraSource Company Profile

    • Table TheraSource Ischemia Reperfusion Injury Revenue, Price and Gross (2018-2023)

    • Table Pharming Company Profile

    • Table Pharming Ischemia Reperfusion Injury Revenue, Price and Gross (2018-2023)

    • Table Prothix Company Profile

    • Table Prothix Ischemia Reperfusion Injury Revenue, Price and Gross (2018-2023)

    • Table Opsona Therapeutics Company Profile

    • Table Opsona Therapeutics Ischemia Reperfusion Injury Revenue, Price and Gross (2018-2023)

    • Table Angion Biomedica Company Profile

    • Table Angion Biomedica Ischemia Reperfusion Injury Revenue, Price and Gross (2018-2023)

    • Table Catalyst Biosciences Company Profile

    • Table Catalyst Biosciences Ischemia Reperfusion Injury Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US